IL6 and metabolic syndrome: Monserrat-Mesquida et al. 2020 conducted a study on 160 adults aged 55 to 80 years in the Balearic Islands, identifying elevated levels of plasma malondialdehyde (MDA), a marker of OS, and pro-inflammatory cytokines such as TNF-α and IL-6 in individuals with MetS.